Skip to content
  • Sunday, 26 July 2026
  • 5:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 16, 2026 0

Rubedo Life Sciences, an AI-driven biotech startup focused on longevity, has announced positive preliminary results from its Phase 1b/2a study…

Read More
Pharmaceutical R&D

Indena and Chemi S.p.A. / Italfarmaco Group Forge Strategic Partnership to Advance Peptide Drug Conjugate Manufacturing

Teuku Ryan Jun 15, 2026 0

The pharmaceutical industry is witnessing a profound evolution in cancer treatment, driven by the escalating demand for highly targeted therapies.…

Read More
Pharmaceutical R&D

Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and Reimbursement

Teuku Ryan Jun 14, 2026 0

In April 2026, Canada’s Drug Agency (CDA) unveiled an expanded dataset, offering a comprehensive look at the trends and intricacies…

Read More
Biotech & Genetic Research

Evosep Proteomics Unveiled: A Unified Ecosystem to Standardize and Scale LC-MS-Based Proteomics for Research and Drug Development

Jia Lissa Jun 5, 2026 0

Evosep, the Odense, Denmark-based innovator in liquid chromatography, has announced a pivotal expansion of its offerings with the launch of…

Read More
Biotech & Genetic Research

Evosep Unveils Evosep Proteomics: A Standardized Ecosystem for Scaling LC-MS-Based Proteomics in Research and Drug Development

Jia Lissa Jun 4, 2026 0

Odense, Denmark – Evosep, a leading innovator in liquid chromatography solutions, has announced the launch of Evosep Proteomics, a comprehensive…

Read More
Laboratory Automation & Robotics

Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access

Lana Keisha Jun 4, 2026 0

In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study

Rifan Muazin Jun 4, 2026 0

A pharmaceutical combination that has become a cornerstone of modern anti-aging and longevity research may pose a severe risk to…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 2, 2026 0

For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…

Read More
Neuroscience & Brain Research

NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus

Rifan Muazin Jun 2, 2026 0

The National Institutes of Health (NIH) has released a groundbreaking study detailing the complex intracellular signaling processes triggered by GLP-1…

Read More
Laboratory Automation & Robotics

The $1.8 Billion Telehealth Conundrum: Medvi’s Rise Amidst Regulatory Gaps, AI Deception, and the Compounded Drug Market

Lana Keisha Jun 1, 2026 0

A recent profile by The New York Times celebrated Medvi, a burgeoning telehealth enterprise, as a testament to the transformative…

Read More

Posts pagination

1 … 3 4 5 … 16
Structural Defects as Charge Highways Scientists Resolve the Mystery of Lead Halide Perovskite EfficiencyScience News: Empowering Public Understanding of Science Since 1921Coordinated Molecular and Physiological Adaptations Enable Activity at Subfreezing Temperatures in the Snow Fly Chionea alexandrianaBrainstem Neural Circuitry Identified as Key Driver of Hypertension Offering New Avenues for Targeted Treatment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ